Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2026 07:45 ET | Source: Fortress Biotech, Inc.

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129...
January 13, 2026 07:01 ET | Source: Research and Markets

Infant Formula Milk & Powder Market - Global Forecast 2025-2032: Abbott, Danone, Nestlé S.A., FrieslandCampina, and Bellamy's Advancing Formulation, Manufacturing Efficiency, and Global Market Reach

Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Infant Formula Milk & Powder Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The global infant...
January 13, 2026 06:59 ET | Source: Research and Markets

Food Service Restaurant Market - Global Forecast 2025-2032: Plant-Based Menu Expansion, Data-Driven Personalization, and Virtual Brand Partnerships Reshape Growth Strategies

Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Food Service Restaurant Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The food service...
January 13, 2026 03:15 ET | Source: Bio Usawa Inc

Bio Usawa Receives Ghana FDA Approval for BioUcenta™

ACCRA, Ghana and KIGALI, Rwanda, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa, Inc.) today announced that the Ghana Food and Drugs Authority (Ghana FDA) has approved...
January 12, 2026 11:42 ET | Source: AstuteAnalytica India Pvt. Ltd.

Recycled Plastic Market to Worth Over US$ 102.40 Billion by 2033 | Astute Analytica

Chicago, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The global recycled plastics market was valued at 50.80 billion in 2024 and is expected to reach US$ 102.40 billion by 2033, growing at a CAGR of 8.1% from...
January 12, 2026 11:05 ET | Source: Biogen Inc.

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1Biogen...
January 12, 2026 08:30 ET | Source: Xenon Pharmaceuticals Inc.

Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference

Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five additional Phase 3 azetukalner studies continuing to enroll patients in...
January 12, 2026 08:30 ET | Source: Outset Medical, Inc.

Outset Medical Reports Unaudited Fourth Quarter and 2025 Results

SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,...
January 12, 2026 08:00 ET | Source: Elutia Inc.

Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones

Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at year-end GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) --...
January 12, 2026 07:50 ET | Source: Research and Markets

Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery

Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "Biomedical and ICT Convergence Market by Technology, Solution and Region 2025-2030" report has been added to ResearchAndMarkets.com's offering. ...